yeah, this is such a shame
how in the world is this all they have after 4 months
their data analysis has always been underwhelming
i honestly felt there was potential with the drug in the correct subgroup, but after seeing management performance (or lack there of), i couldnt stay in
the cap raise is gonna be huge with this on top of FSGS since no indication of any partnership
yeah, this is such a shamehow in the world is this all they have...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $186.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.5¢ | 33.5¢ | $290.3K | 858.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 146134 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 57222 | 2 |
View Market Depth
| Last trade - 16.10pm 23/05/2024 (20 minute delay) ? |
|
|||||
|
Last
34.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 34.0¢ | 34.5¢ | 33.5¢ | 450796 | ||
| Last updated 15.59pm 23/05/2024 ? | |||||
| DXB (ASX) Chart |